Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

  • E. Jabbour
  • , H. Kantarjian
  • , D. Jones
  • , M. Talpaz
  • , N. Bekele
  • , S. O'Brien
  • , X. Zhou
  • , R. Luthra
  • , G. Garcia-Manero
  • , F. Giles
  • , M. B. Rios
  • , S. Verstovsek
  • , J. Cortes

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

353 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science